Fusion Pharma (NASDAQ: FUSN) Stock Doubles Amidst AstraZeneca’s $2 Billion Buyout
Fusion Pharmaceuticals (NASDAQ: FUSN) stock skyrocketed 100% on Tuesday upon news of its $2 billion cash acquisition by AstraZeneca (AZN). […]
Fusion Pharma (NASDAQ: FUSN) Stock Doubles Amidst AstraZeneca’s $2 Billion Buyout Read More »
